Qube Research & Technologies (QRT)
GBIO

Qube Research & Technologies (QRT)’s Generation Bio GBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,559
Closed -$17.8K – 3718
2025
Q2 		$17.8K Buy
+5,559
New +$21.4K ﹤0.01% 3267
2024
Q1 		– Sell
-39
Closed -$637 – 4612
2023
Q4 		$637 Buy
+39
New +$680 ﹤0.01% 3898
2022
Q3 		– Sell
-7,691
Closed -$505K – 2676
2022
Q2 		$505K Buy
+7,691
New +$503K ﹤0.01% 1402
2022
Q1 		– Sell
-2,350
Closed -$166K – 2647
2021
Q4 		$166K Buy
+2,350
New +$410K ﹤0.01% 2026

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GBIO Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Generation Bio (GBIO) in Q3 2025, closing a stake of 5,559 shares — an estimated $17.8K sold.

Qube Research & Technologies (QRT) first reported a position in GBIO in Q4 2021 and held it in 4 quarters. The position peaked at $505K in Q2 2022. 41 funds tracked by Wall St. Rank hold GBIO as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Generation Bio position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5,559 Generation Bio shares in Q3 2025, an estimated $17.8K.
  • Qube Research & Technologies (QRT) first reported a position in Generation Bio in Q4 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Generation Bio position peaked at $505K in Q2 2022.
  • 41 funds tracked by Wall St. Rank held Generation Bio as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.